Two Clinical Research Training Center (CRTC) alumni received an Institutional Research Grant from the American Cancer Society, funded at Siteman Cancer Center at Barnes-Jewish Hospital (BJH) and WashU Medicine. These awards support independent, self-directed investigators early in their careers and enable them to conduct research in areas of special interest to the American Cancer Society.
K12 Oncology alum Felicia Gomez, PhD will serve as the Principal Investigator for the project “Characterizing the Expression Profile of Hodgkin Lymphoma Using Single Nuclei RNA Sequencing,” in which her team will investigate the biology of this disease to understand its etiology, with the goal of creating data that will inform new treatment strategies.
TL1 Predoctoral alum Michael Slade, MD, MSCI will lead the project “CAR T-cell Therapy with Radiation-Based Lymphodepletion for Patients with Myeloma and Advanced Chronic Kidney Disease.” This project aims to improve access to CAR T therapy, including for patients with poor kidney function and members of historically underrepresented groups.